Twenty-five AGs called on the FDA to take urgent action on pulse oximeters' inac...
The PATCH Act’s recently implemented approach to securing medical devices actual...
At the Milken Summit, experts talked about using AI to capture voice biomarkers ...
Ventyx Biosciences ended development of an experimental drug for plaque psoriasi...
A new study finds that the data backing prescription digital therapeutics are la...
The federal government is proposing to place a firmer cap on how much brokers ca...
Democrats hope the outcome on the abortion amendment in Ohio will energize voter...
Government officials, including FDA's Janet Woodcock, proffered a sometimes depr...
With limited research on ketamine's effectiveness against pain, some experts wor...
Longtime cancer doctor Monica Bertagnolli is finally heading to the NIH director...
The number of babies born with congenital syphilis in the U.S. has soared over t...
The FTC is challenging more than 100 patents on brand-name medicines that were i...
TLM-005 is under clinical development by Therillume and currently in Phase I for...
TLM-004 is under clinical development by Therillume and currently in Phase I for...
TLM-003 is under clinical development by Therillume and currently in Phase I for...
StromaForte is under clinical development by Swedish StromaBio and currently in ...
